PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-lll Study

Sinopharm's COVID-19 Vaccine Demonstrates 79% Efficacy in P-III Study

Sinopharm's COVID-19 Vaccine Demonstrates 79% Efficacy in P-III Study

December 31, 2020

Russia's Sputnik V Demonstrates 91.4% Efficacy Against COVID-19

Russia's Sputnik V Demonstrates 91.4% Efficacy Against COVID-19

November 25, 2020

Henlius Present Results of HLX03 (biosimilar- adalimumab) in P-lll Study for Plaque Psoriasis at EADV 2020

Henlius Present Results of HLX03 (biosimilar- adalimumab) in P-lll Study for Plaque Psoriasis at EADV 2020

October 29, 2020

AbbVie Submits Regulatory Applications to the US FDA and EMA for Rinvoq (upadacitinib) to Treat Atopic Dermatitis

AbbVie Submits Regulatory Applications to the US FDA and EMA for Rinvoq (upadacitinib) to Treat Atopic Dermatitis

October 20, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us